Long-Term Results of Medial Unicompartmental Knee Arthroplasty for Knee Avascular Necrosis.


Journal

The Journal of arthroplasty
ISSN: 1532-8406
Titre abrégé: J Arthroplasty
Pays: United States
ID NLM: 8703515

Informations de publication

Date de publication:
03 2019
Historique:
received: 01 08 2018
revised: 29 10 2018
accepted: 05 11 2018
pubmed: 7 12 2018
medline: 10 7 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

Numerous series have documented short and mid-term successes with cemented, metal-backed modern unicompartmental knee arthroplasty (UKA) for avascular osteonecrosis of the knee (AVN). However, data are lacking regarding long-term implant fixation and patient function. The aim of this study is therefore to evaluate the long-term clinical outcome and implant survivorship of patients who underwent UKA for medial knee osteonecrosis (ON). Twenty-nine consecutive UKAs performed by 2 senior surgeons (>50 UKAs a year) in 28 patients (19 women and 9 men with a mean age of 67 years) with medial unicompartmental AVN of the knee between 1989 and 2001 were retrospectively reviewed. AVN was diagnosed using X-ray, magnetic resonance imaging scan, and finally confirmed by postoperative sample analysis. The mean patient body mass index was 27 kg/m At 15 years, survivorship of the components free of revision for any cause was 92% (95% confidence interval 87-97). At latest follow-up, 26 years, survivorship of the components free of revision for any reason was 83% (95% confidence interval 74-95). No survivorship difference was found between the patients suffering from spontaneous or secondary ON of the knee (83% vs 90%, P = .6). At latest follow-up, the mean Knee Society Scoring system Knee was 89 points (range 68-100) and 83 (range 66-96) for Knee Society Scoring system Function. In the longest series to date, medial UKA for treatment of AVN was associated with high survival rates and stable clinical improvement. UKA is a durable and efficient option to treat patients with unicompartmental ON of the knee. IV.

Sections du résumé

BACKGROUND
Numerous series have documented short and mid-term successes with cemented, metal-backed modern unicompartmental knee arthroplasty (UKA) for avascular osteonecrosis of the knee (AVN). However, data are lacking regarding long-term implant fixation and patient function. The aim of this study is therefore to evaluate the long-term clinical outcome and implant survivorship of patients who underwent UKA for medial knee osteonecrosis (ON).
METHODS
Twenty-nine consecutive UKAs performed by 2 senior surgeons (>50 UKAs a year) in 28 patients (19 women and 9 men with a mean age of 67 years) with medial unicompartmental AVN of the knee between 1989 and 2001 were retrospectively reviewed. AVN was diagnosed using X-ray, magnetic resonance imaging scan, and finally confirmed by postoperative sample analysis. The mean patient body mass index was 27 kg/m
RESULTS
At 15 years, survivorship of the components free of revision for any cause was 92% (95% confidence interval 87-97). At latest follow-up, 26 years, survivorship of the components free of revision for any reason was 83% (95% confidence interval 74-95). No survivorship difference was found between the patients suffering from spontaneous or secondary ON of the knee (83% vs 90%, P = .6). At latest follow-up, the mean Knee Society Scoring system Knee was 89 points (range 68-100) and 83 (range 66-96) for Knee Society Scoring system Function.
CONCLUSION
In the longest series to date, medial UKA for treatment of AVN was associated with high survival rates and stable clinical improvement. UKA is a durable and efficient option to treat patients with unicompartmental ON of the knee.
LEVEL OF EVIDENCE
IV.

Identifiants

pubmed: 30503305
pii: S0883-5403(18)31123-9
doi: 10.1016/j.arth.2018.11.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-468

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Matthieu Ollivier (M)

Aix-Marseille University, CNRS, ISM, Institute of Movement Science, Marseille, France; Department of Orthopaedics and Traumatology, APHM, Sainte Marguerite Hospital, Institute for Locomotion, Marseille, France.

Christophe Jacquet (C)

Aix-Marseille University, CNRS, ISM, Institute of Movement Science, Marseille, France; Department of Orthopaedics and Traumatology, APHM, Sainte Marguerite Hospital, Institute for Locomotion, Marseille, France.

Antoine Lucet (A)

Aix-Marseille University, CNRS, ISM, Institute of Movement Science, Marseille, France; Department of Orthopaedics and Traumatology, APHM, Sainte Marguerite Hospital, Institute for Locomotion, Marseille, France.

Sebastien Parratte (S)

Aix-Marseille University, CNRS, ISM, Institute of Movement Science, Marseille, France; Department of Orthopaedics and Traumatology, APHM, Sainte Marguerite Hospital, Institute for Locomotion, Marseille, France.

Jean-Noël Argenson (JN)

Aix-Marseille University, CNRS, ISM, Institute of Movement Science, Marseille, France; Department of Orthopaedics and Traumatology, APHM, Sainte Marguerite Hospital, Institute for Locomotion, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH